Skip to main content
Tech.euFundingExplorerBeta

NLS Pharma

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Total raised
€4.9M
€4,872,673
Funding rounds
2
Investors
1
distinct backers
Active since
2021-09
latest 2025-04

Funding by year

EUR raised per year

Signals

Medium confidence
Raise-next likelihood40
base rate 30% for Other
  • In typical raise window
  • Up-round momentum
Exit likelihood12
base rate 12% (2+ rounds)

    Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

    Funding rounds

    2 rounds
    DateStageAmountInvestors
    2025-04-09Other€2.7MView deal →
    2021-09-28Other€2.2MYA View deal →

    Investors

    1

    Similar companies

    same sector or country